The eosinophil--quo vadis?
- PMID: 14713905
- DOI: 10.1016/j.jaci.2003.10.054
The eosinophil--quo vadis?
Comment on
-
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12. J Allergy Clin Immunol. 2004. PMID: 14699394 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
